(Q35677306)

9 August 2017

1 reference

title

Can natriuretic peptides be used for the diagnosis of diastolic heart failure? (English)

1 reference

Heart failure with preserved ejection fraction

9 August 2017

0 references

1 reference

1 reference

Dahlström U

1

1 reference

9 August 2017

1 March 2004

1 reference

European Journal of Heart Failure

9 August 2017

1 reference

9 August 2017

6

1 reference

9 August 2017

281-287

1 reference

9 August 2017

3

1 reference

Differentiating systolic from diastolic heart failure: pathophysiologic and therapeutic considerations

9 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.005

Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.005

Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.005

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.005

The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.005

ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.005

Determinants of Doppler indexes of left ventricular diastolic function in normal subjects (the Framingham heart study)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.005

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.005

An immunoluminometric assay for N-terminal pro-brain natriuretic peptide: development of a test for left ventricular dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.005

Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.005

Plasma brain natriuretic peptide and atrial natriuretic peptide concentrations correlate with left ventricular end-diastolic pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.005

Determinants of left ventricular filling and of the diastolic pressure-volume relation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.005

Brain natriuretic peptide as a cardiac hormone in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.005

Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.005

Influence of hypertension, left ventricular hypertrophy, and left ventricular systolic dysfunction on plasma N terminal proBNP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.005

Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.005

Cardiac fibrosis in mice lacking brain natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.005

Brain natriuretic peptide appears to act locally as an antifibrotic factor in the heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.005

Brain natriuretic Peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.005

10.1016/J.EJHEART.2004.01.005

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference

PubMed ID

14987577